ARTICLE | Clinical News
ACTOplus met regulatory update
September 5, 2005 7:00 AM UTC
FDA approved an NDA for ACTOplus met to treat Type II diabetes. Takeda hopes to launch the product in October. ACTOplus combines Actos, a peroxisome proliferation activated receptor (PPAR) gamma ago...